Compare Chugai Pharmaceutical Co., Ltd. with Similar Stocks
Dashboard
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 23.71%
- Healthy long term growth as Net Sales has grown by an annual rate of 11.43% and Operating profit at 19.46%
- Company has very low debt and has enough cash to service the debt requirements
The company has declared Positive results for the last 4 consecutive quarters
With ROE of 21.74%, it has a attractive valuation with a 6.45 Price to Book Value
Majority shareholders : Non Institution
Stock DNA
Pharmaceuticals & Biotechnology
JPY 13,855,584 Million (Large Cap)
30.00
NA
0.02%
-0.47
22.39%
7.33
Total Returns (Price + Dividend) 
Chugai Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
Chugai Pharmaceutical Co., Ltd. Reports Strong Financial Performance in Q2 2025
Chugai Pharmaceutical Co., Ltd. has demonstrated impressive financial results for the quarter ending June 2025, showcasing a robust operational performance that has caught the attention of investors. The company, recognized as a large-cap entity, has reported its highest operating cash flow to date, amounting to JPY 464,601 MM.
In addition to its strong cash flow, Chugai Pharmaceutical has also declared a record dividend per share for the half-year, set at JPY 3.59. This reflects the company's commitment to returning value to its shareholders, further evidenced by a significant dividend payout ratio of 211.73%.
The financial health of Chugai Pharmaceutical is further underscored by its substantial cash and equivalents, which stand at JPY 1,972,159 MM. This strong liquidity position allows the company to navigate market fluctuations effect...
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 1 Foreign Institutions (0.0%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 0.54% vs -4.51% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -0.08% vs 6.20% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 5.33% vs -11.79% in Dec 2023
YoY Growth in year ended Dec 2024 is 19.00% vs -13.08% in Dec 2023






